Efficacy of Momordica charantia as a local drug delivery agent in the Treatment of Chronic Periodontitis in patients with Prediabetes A Randomized Controlled Clinical Trial

Manipal College of Dental Sciences Manipal0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Subjects (males and females) in the age range of 30-60 years, having a fasting blood glucose level of 110mg/dl-126 mg/dl will be included in the study. Presence of localized sites of mild to moderate periodontitis with clinical attachment loss of >= 2 mm in either the maxillary or mandibular arch with clinical probing pocket depth of >=5 mm in either the maxillary or mandibular arch and a minimum of twenty retained teeth are other criteria for inclusion

•Subjects with other systemic diseases, taking medications / supplements, previous periodontal therapy within six months of the study plan, pregnant or lactating women, consumption of tobacco or allergy to any medications will not be included in the study.

发起方